Meperidine (Demerol) Market is poised to reach US$ 2,784.3 - GlobeNewswire
SEATTLE, May 05, 2020 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global meperidine (Demerol) market is estimated to be valued at US$ 2,089.1 Mn in 2020, and is expected to exhibit a CAGR of 4.2% during the forecast period (2020-2027). Key Trends and Analysis of the Global Meperidine (Demerol) Market: Meperidine (Demerol) is used as a pain reliever in post-operative pain management, which is expected to support growth of the injectable meperidine. This is also expected to increase demand for meperidine injection sold through hospital pharmacies as it would be sold in the hospitals through this channel. Manufacturers such as Hikma Pharmaceuticals offer injectable forms of the opioid meperidine. Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-sample/3816 Moreover, meperidine offers advantages over other opioids such as lesser risk of addiction, and safer than morphine. Due to its short duration of action and limited analgesi